| Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ... The Lancet 397 (10269), 99-111, 2021 | 5282 | 2021 |
| Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial PM Folegatti, KJ Ewer, PK Aley, B Angus, S Becker, ... The Lancet 396 (10249), 467-478, 2020 | 2758 | 2020 |
| Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial MN Ramasamy, AM Minassian, KJ Ewer, AL Flaxman, PM Folegatti, ... The Lancet 396 (10267), 1979-1993, 2020 | 1656 | 2020 |
| Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four … M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ... The Lancet 397 (10277), 881-891, 2021 | 1328 | 2021 |
| Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19 Y Peng, AJ Mentzer, G Liu, X Yao, Z Yin, D Dong, W Dejnirattisai, ... Nature immunology 21 (11), 1336-1345, 2020 | 1186 | 2020 |
| HIV-Specific Cd8+ T Cells Produce Antiviral Cytokines but Are Impaired in Cytolytic Function V Appay, DF Nixon, SM Donahoe, GMA Gillespie, T Dong, A King, ... The Journal of experimental medicine 192 (1), 63-76, 2000 | 1140 | 2000 |
| Antibody status and incidence of SARS-CoV-2 infection in health care workers SF Lumley, D O’Donnell, NE Stoesser, PC Matthews, A Howarth, ... New England Journal of Medicine 384 (6), 533-540, 2021 | 973 | 2021 |
| SARS-CoV-2 Omicron-B. 1.1. 529 leads to widespread escape from neutralizing antibody responses W Dejnirattisai, J Huo, D Zhou, J Zahradník, P Supasa, C Liu, ... Cell 185 (3), 467-484. e15, 2022 | 901 | 2022 |
| Rapid Detection of Mycobacterium tuberculosisInfection by Enumeration of Antigen-specific T Cells A Lalvani, AA Pathan, H Mcshane, RJ Wilkinson, M Latif, CP Conlon, ... American journal of respiratory and critical care medicine 163 (4), 824-828, 2001 | 757 | 2001 |
| European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease JF Rahier, S Ben-Horin, Y Chowers, C Conlon, P De Munter, G D'Haens, ... Journal of Crohn's and Colitis 3 (2), 47-91, 2009 | 689 | 2009 |
| Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27–restricted cytotoxic T lymphocyte responses AD Kelleher, C Long, EC Holmes, RL Allen, J Wilson, C Conlon, ... The Journal of experimental medicine 193 (3), 375-386, 2001 | 588 | 2001 |
| Immune Activation and CD8+ T-Cell Differentiation towards Senescence in HIV-1 Infection L Papagno, CA Spina, A Marchant, M Salio, N Rufer, S Little, T Dong, ... PLoS biology 2 (2), e20, 2004 | 574 | 2004 |
| Antibody escape of SARS-CoV-2 Omicron BA. 4 and BA. 5 from vaccine and BA. 1 serum A Tuekprakhon, R Nutalai, A Dijokaite-Guraliuc, D Zhou, HM Ginn, ... Cell 185 (14), 2422-2433. e13, 2022 | 570 | 2022 |
| Differential occupational risks to healthcare workers from SARS-CoV-2 observed during a prospective observational study DW Eyre, SF Lumley, D O'Donnell, M Campbell, E Sims, E Lawson, ... elife 9, e60675, 2020 | 271 | 2020 |
| Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine RP Payne, S Longet, JA Austin, DT Skelly, W Dejnirattisai, S Adele, ... Cell 184 (23), 5699-5714. e11, 2021 | 267 | 2021 |
| A human immunodeficiency virus 1 (HIV-1) clade A vaccine in clinical trials: stimulation of HIV-specific T-cell responses by DNA and recombinant modified vaccinia virus Ankara … M Mwau, I Cebere, J Sutton, P Chikoti, N Winstone, EGT Wee, T Beattie, ... Journal of General Virology 85 (4), 911-919, 2004 | 263 | 2004 |
| Assessment of Mycobacterium tuberculosis transmission in Oxfordshire, UK, 2007–12, with whole pathogen genome sequences: an observational study TM Walker, MK Lalor, A Broda, LS Ortega, M Morgan, L Parker, ... The Lancet Respiratory Medicine 2 (4), 285-292, 2014 | 240 | 2014 |
| A systematic review of the antifungal effectiveness and tolerability of amphotericin B formulations JP Barrett, KA Vardulaki, C Conlon, J Cooke, P Daza-Ramirez, ... Clinical therapeutics 25 (5), 1295-1320, 2003 | 231 | 2003 |
| T-cell and antibody responses to first BNT162b2 vaccine dose in previously infected and SARS-CoV-2-naive UK health-care workers: a multicentre prospective cohort study A Angyal, S Longet, SC Moore, RP Payne, A Harding, T Tipton, ... The Lancet Microbe 3 (1), e21-e31, 2022 | 188* | 2022 |
| Outpatient parenteral antimicrobial therapy (OPAT): is it safe for selected patients to self-administer at home? A retrospective analysis of a large cohort over 13 years PC Matthews, CP Conlon, AR Berendt, J Kayley, L Jefferies, BL Atkins, ... Journal of antimicrobial chemotherapy 60 (2), 356-362, 2007 | 188 | 2007 |
